Literature DB >> 25640228

Comparison of Bio-Revitalizing Injective Products: A Study on Skin Fibroblast Cultures.

Anna Avantaggiato1, Ambra Girardi2, Annalisa Palmieri2, Michele Pascali3, Francesco Carinci1.   

Abstract

Bio-revitalization is a commonly used technique in aesthetic medicine for improving skin quality and appearance by intra-dermal injection of hyaluronic acid (HA)-containing compounds. The present study compares different HA-containing injectables regarding their effects on cultured skin fibroblasts over time (24, 48, and 72 hr) by using RT-PCR and a panel of genes involved in dermal integrity. Human dermal fibroblasts were seeded on a layer of five different commercial medical devices containing 6.2 mg/mL 10 mg/mL 10%, 13 mg/mL and 20 mg/mL, respectively, of HA. The products differ not only in HA concentration but also in the content and quality of other ingredients; moreover, one of these products contained cross-linked HA. Differences among medical devices were found. In particular, HA concentration seems to be inversely correlated to elastin gene activation. Regarding the neutrophil elastase gene, the two medical devices with the higher concentration of HA displayed the greater effect. Genes encoding for hyaluronan synthase 1, hyaluronidase 1, and desmoplakin were enhanced, but the HA content of the different products did not seem to be directly related to gene activation. Therefore, the explanation for the differences must be studied further with respect to elements that are distinctive for each device. For the physician, it is important to choose which drugs or medical devices can be used and in what protocols. The present study performed a comparison that can be useful in better addressing the skin improvement therapies for aging and in its prevention.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25640228     DOI: 10.1089/rej.2014.1654

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  4 in total

1.  Heterologous Type I Collagen as an Add-on Therapy to Narrowband Ultraviolet B for the Treatment of Vitiligo: A Pilot Study.

Authors:  Aikaterini Gkouvi; Electra Nicolaidou; Andreas Corbo; Gennaro Selvaggi; Antonis Tsimpidakis; Styliani Mastraftsi; Stamatios Gregoriou
Journal:  J Clin Aesthet Dermatol       Date:  2021-06-01

2.  In vitro study of RRS HA injectable mesotherapy/biorevitalization product on human skin fibroblasts and its clinical utilization.

Authors:  Pierre-Antoine Deglesne; Rodrigo Arroyo; Evgeniya Ranneva; Philippe Deprez
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-02-23

3.  Efficacy and tolerance of an injectable medical device containing stable hybrid cooperative complexes of high- and low-molecular-weight hyaluronic acid: a monocentric 16 weeks open-label evaluation.

Authors:  Adele Sparavigna; Beatrice Tenconi
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-09-26

4.  Effects of light-emitting diode (led 640nm) on human gingival fibroblasts: a comparative in vitro study.

Authors:  P M Mandrillo; G Fischetto; P Odorisio; F Cura; A Avantaggiato; F Carinci
Journal:  Oral Implantol (Rome)       Date:  2017-09-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.